LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Mississippi MS
Legislatures
2025 Regular Session
House
Bills
HB1121
MS
Mississippi House Bill HB1121
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Mississippi 2025 Regular Session
Mississippi House Bill HB1121
Introduced
1/20/25
Refer
1/20/25
Failed
2/13/25
Caption
Kratom; add to Schedule III of the Uniform Controlled Substances Act.
Latest MS HB1121 Activity
View All Events: MS 2025 Regular Session HB1121
Companion Bills
No companion bills found.
Previously Filed As
MS HB1038
Kratom; add to Schedule III of the Uniform Controlled Substances Act.
MS SB2370
Uniform Controlled Substances Act; include certain substances within Schedule III.
MS HB1685
Uniform Controlled Substances Act; revise schedules.
MS HB4
Tianeptine; include in Schedule I controlled substance list.
MS HB1467
Uniform Controlled Substances Act; revise schedules.
MS SB2279
Uniform Controlled Substances Act; revise schedules.
MS HB1342
Controlled substances; bring forward sections for unlawful possession of.
MS HB1071
Uniform Controlled Substances Act; revise schedules.
MS SB2283
Uniform Controlled Substances Act; revise schedules.
MS HB5
Kratom; include in Schedule I controlled substances list.
Similar Bills
MS HB4
Tianeptine; include in Schedule I controlled substance list.
MS SB2355
Kratom; add to Schedule III of the Uniform Controlled Substances Act.
MS SB2370
Uniform Controlled Substances Act; include certain substances within Schedule III.
MS SB2214
Kratom; add to Schedule III of the Uniform Controlled Substances Act.
MS HB1122
Kratom; add to Schedule III of the Uniform Controlled Substances Act.
MS HB1038
Kratom; add to Schedule III of the Uniform Controlled Substances Act.
VA HB1187
Xylazine; penalty for manufacturing, selling, etc., for human consumption.
VA SB614
Xylazine; penalty for manufacturing, selling, etc., for human consumption.